S-0.1, r. 12 - Regulation respecting drugs that a midwife may prescribe or administer in the practice of midwifery

Updated to 1 September 2012

This document has official status.

chapter S-0.1, r. 12

Regulation respecting drugs that a midwife may prescribe or administer in the practice of midwifery

Midwives Act

(chapter S-0.1, s. 9, 1st par.).

1. The drugs that a midwife may prescribe or administer are

(1)  the drugs for the mother listed in Schedule I, on the conditions, if applicable, determined in the Schedule; and

(2)  the drugs for the child listed in Schedule II, on the conditions determined in the Schedule.

O.C. 967-2008, s. 1.

2. (Omitted).

O.C. 967-2008, s. 2.

SCHEDULE I

(s. 1)

DRUGS THAT A MIDWIFE MAY PRESCRIBE OR ADMINISTER TO THE MOTHER

Substances                           Specifications and conditions

Acetaminophen                        For use during the prenatal and postpartum 
                                     period

Acetaminophen and codeine            Pharmaceutical form containing 325 mg or less
(in combination)                     of acetaminophen and 30 mg or less of codeine 
                                     per tablet
                                     Limited quantity for a 2-day period

Acetaminophen, caffeine and          Pharmaceutical form containing 300 mg or less 
codeine (in combination)             of acetaminophen, 15 mg or less of caffeine 
                                     and 8 mg or less of codeine per tablet
                                     Limited quantity for a 2-day period

Alginic acid

Aluminum hydroxide and magnesium hydroxide

Ampicillin                           Pharmaceutical form for parenteral 
                                     administration in prophylaxis during the 
                                     prolonged rupture of membranes in asymptomatic 
                                     women or in prophylaxis in respect of 
                                     beta-hemolytic streptococcus

Betamethasone, clotrimazole and      Pharmaceutical form for topical administration 
mupirocin (in combination)           in a concentration of 0.1% betamethasone, 10% 
                                     clotrimazole and 2% mupirocin for the 
                                     treatment of fungal infections on nipples of 
                                     breastfeeding women

Betamethasone, miconazole and        Pharmaceutical form for topical administration 
mupirocin (in combination)           in a concentration of 0.1% betamethasone, 2% 
                                     miconazole and 2% mupirocin for the treatment
                                     of fungal infections on nipples of 
                                     breastfeeding women

Calcium carbonate

Calcium gluconate                    Pharmaceutical form for parenteral 
                                     administration in a concentration of 10% as 
                                     antidote for magnesium sulphate while awaiting 
                                     transfer of clinical responsibility to a 
                                     physician

Carboprost tromethamine              Pharmaceutical form for parenteral 
                                     administration in a concentration of 0.25 mg 
                                     in prophylaxis or if hemorrhage during the 
                                     immediate postpartum period and synthetic 
                                     oxytocin is ineffective

Clindamycin                          Pharmaceutical form for parenteral 
                                     administration in prophylaxis in respect of 
                                     beta-hemolytic streptococcus, if allergy to 
                                     penicillin G

Clotrimazole                         Pharmaceutical forms for topical and vaginal 
                                     administration in a concentration of 1%

Dextrose                             Pharmaceutical form for parenteral infusion 
                                     administration in a concentration of 5% 
                                     Or
                                     Pharmaceutical form for oral administration 
                                     for a glucose tolerance test

Dextrose and sodium chloride         Pharmaceutical form for parenteral infusion 
(in combination)                     administration in a concentration of 5% 
                                     dextrose and 0.45% sodium chloride 

Diazepam                             Pharmaceutical form for rectal administration
                                     for the treatment of seizures, if magnesium 
                                     sulphate is ineffective

Diphenhydramine hydrochloride        Pharmaceutical form for parenteral 
                                     administration for the treatment of allergic 
                                     reactions, with or without anaphylactic 
                                     reaction, with no increased body temperature 
                                     or systemic illness

Docusate calcium                     Pharmaceutical form for oral administration 
                                     during the prenatal and postpartum period

Docusate sodium                      Pharmaceutical form for oral administration 
                                     during the prenatal and postpartum period

Doxylamine succinate and             Pharmaceutical form containing 10 mg of 
pyridoxine hydrochloride             doxylamine succinate and 10 mg of pyridoxine 
(in combination)                     hydrochloride per tablet

Epinephrine                          Presented in the form of auto-injector or 
                                     ampoule in a concentration of 1 mg/ml for the 
                                     emergency treatment of anaphylactic reactions

Ergonovine maleate                   Pharmaceutical form for parenteral 
                                     administration in prophylaxis or if hemorrhage 
                                     during the immediate postpartum period and 
                                     synthetic oxytocin is ineffective

Erythromycin                         Pharmaceutical form for parenteral 
                                     administration in prophylaxis in respect of 
                                     beta-hemolytic streptococcus, if allergy to 
                                     penicillin G and resistance to clindamycin

Ferrous fumarate                     Pharmaceutical form for oral administration, 
                                     if intolerance to ferrous sulphate 

Ferrous gluconate                    Pharmaceutical form for oral administration,
                                     if intolerance to ferrous sulphate or ferrous 
                                     fumarate

Ferrous sulphate                     Pharmaceutical form for oral administration

Folic acid                           Pharmaceutical form for oral administration 
                                     during the prenatal period

Glycerin                             Pharmaceutical form for rectal administration

Hamamelis and glycerin               Pharmaceutical form for topical administration 
(in combination)                     in a concentration of 50% hamamelis

Human immunoglobulin                 Pharmaceutical form for parenteral 
                                     administration during the prenatal and 
                                     postpartum period

Hydrocortisone and zinc              Pharmaceutical form for rectal administration 
sulphate (in combination)            in a concentration of 0.5% hydrocortisone and 
                                     0.5% zinc sulphate

Ibuprofen                            For use during the postpartum period

Lidocaine                            Pharmaceutical form for topical administration 
                                     in a concentration of 4% for action on vaginal 
                                     mucus while repairing minor lacerations
                                     Or
                                     Pharmaceutical form for parenteral 
                                     administration in a concentration of 1%

Lorazepam                            Pharmaceutical forms for oral and sublingual 
                                     administration for manual removal of the 
                                     placenta, if hemorrhage

Magnesium sulphate                   Pharmaceutical form for parenteral 
                                     administration for the treatment of seizures

Miconazole                           Pharmaceutical forms for topical and vaginal 
                                     administration during the prenatal period in a 
                                     concentration of 2%

Misoprostol                          Pharmaceutical forms for oral or rectal 
                                     administration if hemorrhage during the 
                                     immediate postpartum period or synthetic 
                                     oxytocin is ineffective or unavailable

MMR vaccine                          Pharmaceutical form for parenteral 
                                     administration during the postpartum period

Morphine                             Pharmaceutical form for parenteral 
                                     administration during the neonatal period in 
                                     prolonged latency in primiparous women and 
                                     during the postpartum period

Multivitamins and minerals 

Nitroglycerin                        Pharmaceutical form for sublingual spray 
                                     administration if excessive uterine activity 
                                     with a non-reassuring fetal heart rate or 
                                     prolapsed cord

Penicillin G                         Pharmaceutical form for parenteral 
                                     administration in prophylaxis in respect of 
                                     beta-hemolytic streptococcus

Psyllium (mucilage)                  Pharmaceutical form for oral administration 
                                     during the prenatal and postpartum period

Ringer’s lactate                     Pharmaceutical form for parenteral infusion 
                                     administration for fluid replacement if 
                                     substantial postpartum loss of blood or if 
                                     hemorrhage

Sodium chloride                      Pharmaceutical form for parenteral infusion 
                                     administration in a concentration of 0.9% for 
                                     fluid replacement if substantial postpartum 
                                     loss of blood, if hemorrhage or for dilution

Sodium citrate/sodium lauryl         Pharmaceutical form for rectal administration
sulfate

Synthetic oxytocin                   Pharmaceutical form for parenteral 
                                     administration in prophylaxis or if hemorrhage 
                                     during the immediate postpartum period

Terconazole                          Pharmaceutical forms for topical and vaginal 
                                     administration during the prenatal period in a 
                                     concentration of 0.4%, if clotrimazole and 
                                     miconazole are ineffective

Vitamin B6                           Pharmaceutical form for oral administration 
                                     for the treatment of nausea during the 
                                     prenatal period

Vitamin B12                          For use during the prenatal period

Vitamin D and calcium                Pharmaceutical form for oral administration in
(in combination)                     prophylaxis

O.C. 967-2008, Sch. I.

SCHEDULE II

(s. 1)

DRUGS THAT A MIDWIFE MAY PRESCRIBE OR ADMINISTER TO THE CHILD

Substances                           Specifications and conditions

Ampicillin                           Pharmaceutical form for parenteral 
                                     administration in newborns having an emergency 
                                     condition and after a medical consultation

Epinephrine                          Pharmaceutical forms for parenteral and 
                                     endotracheal administration in a concentration 
                                     of 0.1 mg/ml during neonatal resuscitation

Erythromycin                         Pharmaceutical form for ophthalmic 
                                     administration in a concentration of 0.5% in
                                     prophylaxis in newborns

Gentamicin                           Pharmaceutical form for parenteral 
                                     administration in newborns having an emergency 
                                     condition and after a medical consultation

Gentian violet                       Pharmaceutical form for topical 
                                     administration, in a water solution, in a 
                                     concentration of 1% or less

Hepatitis B immune globulin          Pharmaceutical form for parenteral 
                                     administration

Hepatitis B vaccine                  Pharmaceutical form for parenteral 
                                     administration

Naloxone hydrochloride               Pharmaceutical form for parenteral 
                                     administration in a concentration of 0.4 mg/ml 
                                     in newborns having an emergency condition

Nystatin                             Pharmaceutical form for oral administration,
                                     presented in the form of a suspension for the 
                                     treatment of non-recurrent, non- resistant 
                                     oral mycosis

Penicillin G                         Pharmaceutical form for parenteral 
                                     administration in newborns having an emergency 
                                     condition and after a medical consultation

Sodium chloride                      Pharmaceutical form for parenteral infusion 
                                     administration in a concentration of 0.9% in 
                                     newborns having an emergency condition or for 
                                     dilution

Vitamin D                            Pharmaceutical form for oral administration in 
                                     breastfed infants

Vitamin K1                           Pharmaceutical form for parenteral and 
                                     oral administration

O.C. 967-2008, Sch. II.

REFERENCES

O.C. 967-2008, 2008 G.O. 2, 5005